Trials / Terminated
TerminatedNCT03216863
Home Respiratory Rehabilitation in Advanced Lung Cancer Chemotherapy Per os
Home Respiratory Rehabilitation in Patients With Lung Cancer Non-small Cell Advanced or Metastatic Treated With Oral Targeted Therapy
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The feasibility and impact of respiratory rehabilitation (RR) in patients with advanced or metastatic (EGF-R WT or mutated) non-small cell lung cancer treated with oral targeted therapy including Inhibitors of EGF-R tyrosine kinases (TKI) and ALK inhibitors. These patients will benefit, at the beginning of the chemotherapy whatever the treatment line, of a respiratory rehabilitation. The respiratory rehabilitation takes place at the patient's home with the HAD's cooperation 3 hours per week, divided into 2 or 3 sessions. There is associated educational, nutritional and psychological support for a total duration of 8 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Respiratory rehabilitation | It consists of a global care of the patient: therapeutic education, nutritional maintenance, psychological support and re-training to the effort at home after discharge or after follow up visit of targeted therapy |
Timeline
- Start date
- 2015-08-03
- Primary completion
- 2017-08-01
- Completion
- 2017-08-01
- First posted
- 2017-07-13
- Last updated
- 2018-05-16
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03216863. Inclusion in this directory is not an endorsement.